Evidence map›Paper›PMID 31311917›Full record

ArticleOncogenesis2019

Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia.

Clément Larrue, Quentin Heydt, Estelle Saland, Héléna Boutzen, Tony Kaoma, Jean-Emmanuel Sarry, Carine Joffre, Christian Récher

Open access · goldAbstract read
In one paragraph

Article in Oncogenesis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The dual role of autophagy in acute myeloid leukemia.Journal of hematology & oncology · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Clément LarrueCancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France.
Quentin HeydtCancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France.
Estelle SalandCancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France.
Héléna BoutzenCancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France.
Tony KaomaProteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, Strassen, Luxembourg.
Jean-Emmanuel SarryCancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France.
Carine JoffreCancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France.ORCID http://orcid.org/0000-0002-7551-356X
Christian RécherCancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France. recher.christian@iuct-oncopole.fr.ORCID http://orcid.org/0000-0002-3332-4525
Centre National de la Recherche Scientifique · FRLuxembourg Institute of Health · LU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy is associated with both survival and cell death in myeloid malignancies. Therefore, deciphering its role in different genetically defined subtypes of acute myeloid leukemia (AML) is critical. Activating mutations of the KIT receptor tyrosine kinase are frequently detected in core-binding factor AML and are associated with a greater risk of relapse. Herein, we report that basal autophagy was significantly increased by the KIT

Identifiers

PMID31311917
PMCPMC6635375
OpenAlexW2962236287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.